Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Emma Svennberg , David Duncker Added: 2 years ago
In this video from Arrhythmia Academy's Journal Club, Dr David Duncker (Hannover Heart Rhythm Center, Hannover, Germany) and Dr Emma Svennberg (Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden) sit down to discuss screening options for atrial fibrillation. Dr Svennberg presents the results from the STROKESTOP study, which then leads into a discussion in regards to the… View more
Author(s): Carlo Pappone , Vincenzo Santinelli Added: 3 years ago
Atrial fibrillation (AF) is the most common cardiac arrhythmia and is associated with an increased risk of morbidity and mortality.1 Despite important advances in its treatment, AF remains an independent predictor of both morbidity and mortality. Morbidity is related to frequent hospitalisations due to debilitating symptoms, heart failure (HF), stroke and systemic thromboembolism. The rise in… View more
Author(s): Yousif Ahmad , Gregory YH Lip Added: 3 years ago
Atrial fibrillation (AF) leads to a prothrombotic state1 and places patients at risk of thromboembolic disease. The most common and serious complication of thromboembolism is stroke, and AF is held responsible for 25 % of all strokes.2 Strokes in the context of AF are associated with a higher mortality, longer hospital stay and lower levels of independence at discharge.3 These factors combine to… View more
Author(s): Harold Rivner , Raul D Mitrani , Jeffrey J Goldberger Added: 3 years ago
AF is the most common sustained cardiac rhythm disturbance.1 Worldwide, there is an estimated 33.5 million people with AF as of 2010.2 While there are multiple estimates, the yearly incidence in the US is expected to grow, for example, from 1.2 million cases in 2010 to 2.6 million cases in 2030 and upwards of 6–12 million cases by 2050.1,3 It is associated with increased morbidity and mortality4… View more
Author(s): Mark M Gallagher Added: 8 years ago
Dr Mark Gallagher discusses 'Treatment of Atrial Fibrillation' with Radcliffe Cardiology This video interview was conducted at the ‘Advances in the Pathogenesis and Management of Cardiovascular Disease’ meeting held at the Royal College of Surgeons in London, UK on the 27th November 2015. View more
Author(s): James A Reiffel Added: 3 years ago
Atrial fibrillation (AF) is the most common sustained, medically significant, and troublesome arrhythmia encountered in clinical practice. AF has been associated with decreased quality of life (symptoms), serious morbidity (thromboemboli and tachycardia-induced cardiomyopathy), and increased risk of mortality. Several articles1,2 have reviewed this arrthymia in depth including its presentations,… View more
Author(s): James A Reiffel Added: 3 years ago
Atrial fibrillation (AF) is the most common sustained, medically significant, and troublesome arrhythmia encountered in clinical practice. AF has been associated with decreased quality of life (symptoms), serious morbidity (thromboemboli and tachycardia-induced cardiomyopathy), and increased risk of mortality. Several articles have reviewed this arrthymia in depth including its presentations,… View more
Author(s): Freek WA Verheugt Added: 3 years ago
The yearly incidence of stroke in patients with atrial fibrillation (AF) is approximately 5%,1 which is five times higher than in comparable populations in sinus rhythm (SR). The stroke risk largely depends on the underlying heart disease. In 'lone' AF (absence of heart disease) the stroke risk is only 0.5% per year,2 whereas in AF associated with rheumatic valvular heart disease (VHD), like… View more